Literature DB >> 9918773

An ELISA for RNA helicase activity: application as an assay of the NS3 helicase of hepatitis C virus.

C C Hsu1, L H Hwang, Y W Huang, W K Chi, Y D Chu, D S Chen.   

Abstract

A convenient enzyme-linked immunosorbent assay (ELISA) for RNA helicase activity was developed with principles similar to the standard assay. The helicase ELISA utilizes a non-radioactive double-stranded substrate with a biotin-labeled template (long) strand hybridized to a digoxigenin (DIG)-labeled release (short) strand. The template strand binds to the wells of streptavidin-coated microtiter plates (SA-MTP) where the helicase catalyzes the unwinding reaction. Substrate not unwound retains the DIG-labeled release strand and is detected using anti-DIG coupled to horseradish peroxidase. Chromogenic detection follows. Absorbance measurement allows determination of unwinding efficiency of reactions. To demonstrate effectiveness, the ELISA-based assay was used to study the unwinding activity of the hepatitis C virus (HCV) NS3 helicase. Using a known inhibitor of NS3 helicase activity and two mutant HCV helicases, the ability of the assay to screen potential anti-helicase drugs and putative helicases is illustrated. The helicase ELISA is more convenient than the standard helicase assay and is especially suited for the testing of large numbers of samples.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9918773     DOI: 10.1006/bbrc.1998.9813

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Identification of genes by hybrid ribozymes that couple cleavage activity with the unwinding activity of an endogenous RNA helicase.

Authors:  Hiroaki Kawasaki; Kazunari Taira
Journal:  EMBO Rep       Date:  2002-04-18       Impact factor: 8.807

2.  Helicase inhibitors as specifically targeted antiviral therapy for hepatitis C.

Authors:  Craig A Belon; David N Frick
Journal:  Future Virol       Date:  2009-05-01       Impact factor: 1.831

Review 3.  Helicases as antiviral drug targets.

Authors:  David N Frick
Journal:  Drug News Perspect       Date:  2003 Jul-Aug

4.  Monitoring helicase activity with molecular beacons.

Authors:  Craig A Belon; David N Frick
Journal:  Biotechniques       Date:  2008-10       Impact factor: 1.993

5.  A graphene-based platform for the assay of duplex-DNA unwinding by helicase.

Authors:  Hongje Jang; Young-Kwan Kim; Hyun-Mi Kwon; Woon-Seok Yeo; Dong-Eun Kim; Dal-Hee Min
Journal:  Angew Chem Int Ed Engl       Date:  2010-08-02       Impact factor: 15.336

6.  A Graphene-Based Platform for the Assay of Duplex-DNA Unwinding by Helicase.

Authors:  Hongje Jang; Young-Kwan Kim; Hyun-Mi Kwon; Woon-Seok Yeo; Dong-Eun Kim; Dal-Hee Min
Journal:  Angew Chem Weinheim Bergstr Ger       Date:  2010-07-07

Review 7.  Discovering new medicines targeting helicases: challenges and recent progress.

Authors:  William R Shadrick; Jean Ndjomou; Rajesh Kolli; Sourav Mukherjee; Alicia M Hanson; David N Frick
Journal:  J Biomol Screen       Date:  2013-03-27

Review 8.  A new helicase assay based on graphene oxide for anti-viral drug development.

Authors:  Hongje Jang; Soo-Ryoon Ryoo; Min Jae Lee; Sang Woo Han; Dal-Hee Min
Journal:  Mol Cells       Date:  2013-03-11       Impact factor: 5.034

9.  An in silico and in vitro pipeline for the rapid screening of helicase modulators.

Authors:  Eleni Papakonstantinou; Flora Bacopoulou; Vasileios Megalooikonomou; Aspasia Efthimiadou; Dimitrios Vlachakis
Journal:  EMBnet J       Date:  2020-02-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.